MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,936 Cr | ₹1,778 Cr | ₹1,293 Cr | ₹1,110 Cr | ₹1,070 Cr |
What is the latest Total Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹1,936 Cr |
| Mar2025 | ₹1,778 Cr |
| Mar2024 | ₹1,293 Cr |
| Mar2023 | ₹1,110 Cr |
| Mar2022 | ₹1,070 Cr |
How is Total Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,936 Cr | 8.89 | |
| Mar2025 | ₹1,778 Cr | 37.50 | |
| Mar2024 | ₹1,293 Cr | 16.45 | |
| Mar2023 | ₹1,110 Cr | 3.78 | |
| Mar2022 | ₹1,070 Cr | - | |
Compare Total Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹5,466.3 Cr | 3.3% | -22% | 105.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 3.3% |
-22% |
105.6% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses